Yahoo
Helsinki - Delayed Quote EUR

Optomed Oyj (OPTOMED.HE)

1.4100 +0.0420 (+3.07%)
At close: October 30 at 6:29:50 PM GMT+2
Chart Range Bar
Loading chart for OPTOMED.HE
  • Previous Close 1.3680
  • Open 1.3680
  • Bid 1.4060 x --
  • Ask 1.4100 x --
  • Day's Range 1.3220 - 1.4100
  • 52 Week Range 1.3220 - 4.3300
  • Volume 31,709
  • Avg. Volume 37,868
  • Market Cap (intraday) 30.278M
  • Beta (5Y Monthly) 1.56
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2800
  • Earnings Date Nov 6, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 2.37

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists' work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed Radiology Information System, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.

www.optomed.com

110

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .

YTD Return

OPTOMED.HE
62.60%
OMX Helsinki_PI (^OMXHPI)
0.00%

1-Year Return

OPTOMED.HE
64.08%
OMX Helsinki_PI (^OMXHPI)
0.00%

3-Year Return

OPTOMED.HE
43.60%
OMX Helsinki_PI (^OMXHPI)
0.00%

5-Year Return

OPTOMED.HE
86.51%
OMX Helsinki_PI (^OMXHPI)
0.00%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 3.35M
Earnings -1.1M
Profit Margin -32.86%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
2M
4M
-42.0%
-40.0%
-38.0%
-36.0%
-34.0%

Analyst Insights

View More

Analyst Price Targets

1.80
2.37 Average
1.4100 Current
3.30 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -33.86%

  • Return on Assets (ttm)

    -12.47%

  • Return on Equity (ttm)

    -25.43%

  • Revenue (ttm)

    16.1M

  • Net Income Avi to Common (ttm)

    -5.45M

  • Diluted EPS (ttm)

    -0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.69M

  • Total Debt/Equity (mrq)

    10.84%

  • Levered Free Cash Flow (ttm)

    -2.69M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: